Studying skin growths to better tell them apart
Part of Cancer, Skin clinical trials.
This study looks at different types of skin growths (actinic keratosis or cSCC) to understand their unique features. It may help doctors better tell apart harmless from dangerous skin spots by studying cells and inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a skin spot that your doctor thinks may be actinic keratosis or a form of cSCC (a type of skin cancer).
- You have not received chemotherapy or immunotherapy for this condition before.
- The skin spot is not on a visible part of your face or in a skin fold (like behind the ear).
- You are able to sign a consent form and are covered by French Social Security.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized aftercare report for people with low-risk skin cancer. It aims to see if this report can improve follow-up care.
This trial tests a new educational program to help people learn how to check their own skin for signs of skin cancer. It aims to make early detection easier, and you can join regardless of whether you have had skin cancer before.
This trial uses advanced imaging to take detailed pictures of your skin. It may help doctors better understand and diagnose skin conditions.
This study looks at how different types of cells behave in people with mild forms of mastocytosis (a condition with too many mast cells in the skin). Researchers will take skin samples to understand the disease better, which may help develop future treatments.
This study looks at how doctors stage (classify the extent of) a type of skin cancer called cutaneous squamous cell carcinoma. You may be helping researchers by allowing your clinical data to be used for research.
This study uses information from a European registry to learn how real-world treatments work for advanced non-melanoma skin cancers. It may help doctors improve care in the future, especially for people who have had surgery and radiation or who cannot have curative treatments.
Hear when a new Skin Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.